Blueprint Medicines Corp
BPMC
View Detailed Chart
129.460USD
0.000
Close 12/19, 16:00（ET）Quotes delayed by 15 min
8.36BMarket Cap
LossP/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
0.00%
5 Days
0.00%
1 Month
0.00%
6 Months
+0.98%
Year to Date
+48.43%
1 Year
+43.62%
View Detailed Chart
TradingKey Stock Score
No stock score available due to insufficient data.
Blueprint Medicines Corp News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Blueprint Medicines Corp Info
Blueprint Medicines Corporation is a global precision therapy company that is inventing life-changing medicines in two areas of allergy/inflammation and oncology/hematology. The Company delivers its approved medicines, including AYVAKIT/AYVAKYT (avapritinib) and GAVRETO (pralsetinib), to patients in the United States and Europe, and it is globally advancing multiple programs for systemic mastocytosis (SM), lung cancer, breast cancer and other genomically defined cancers, and cancer immunotherapy. Its pipelines also include Elenestinib (BLU-263) (KIT), AYVAKIT (avapritinib) (KIT), Wild-type KIT research program, GAVRETO (pralsetinib) (RET), BLU-945 (EGFR), BLU-525 (EGFR), BLU-451 (EGFR exon 20 insertions), BLU-222 (CDK2), AYVAKIT (PDGFRA), GAVRETO (RET), BLU-222 (CDK2) and BLU-852 (MAP4K1). It is developing elenestinib (BLU-263), an investigational, orally available, potent and highly selective KIT inhibitor, for the treatment of indolent SM and other mast cell disorders.
Ticker SymbolBPMC
CompanyBlueprint Medicines Corp
CEOMs. Kathryn D (Kate) Haviland
Websitehttps://www.blueprintmedicines.com/
FAQs
What is the current price of Blueprint Medicines Corp (BPMC)?
The current price of Blueprint Medicines Corp (BPMC) is 129.460.
What is the symbol of Blueprint Medicines Corp?
The ticker symbol of Blueprint Medicines Corp is BPMC.
What is the 52-week high of Blueprint Medicines Corp?
The 52-week high of Blueprint Medicines Corp is 129.650.
What is the 52-week low of Blueprint Medicines Corp?
The 52-week low of Blueprint Medicines Corp is 73.040.
What is the market capitalization of Blueprint Medicines Corp?
The market capitalization of Blueprint Medicines Corp is 8.36B.
What is the net income of Blueprint Medicines Corp?
The net income of Blueprint Medicines Corp is -67.09M.
Is Blueprint Medicines Corp (BPMC) currently rated as Buy, Hold, or Sell?
According to analysts, Blueprint Medicines Corp (BPMC) has an overall rating of --, with a price target of --.
What is the Earnings Per Share (EPS TTM) of Blueprint Medicines Corp (BPMC)?
The Earnings Per Share (EPS TTM) of Blueprint Medicines Corp (BPMC) is 0.008.
